IDweek Poster No397 Final Corrected
IDweek Poster No397 Final Corrected
IDweek Poster No397 Final Corrected
1,2
1,2
2
1,2
Ana Vsquez, MD ; Renato A. Errea, MD ; Daniel Hoces, MD ; Elsa Gonzlez, MD ; Eduardo
Referral Hospital in
Lima-Peru
1,2,3
No.
397
Gotuzzo, MD
Contact
School of Medicine - Universidad Peruana Cayetano Heredia (UPCH), 2Instituto de Medicina Tropical Alexander von Humboldt UPCH Hospital
Cayetano
Heredia,
Lima
Fig 1. Initial and follow-up HIV testing among eligible partners
Abstract
Methods
characteristics between index cases and their partners enrolled in
Background
Conclusion:
Under
this routine conditions,
there
are still
Given that HIV
transmission
is primarily
driven
by missed
sexual
opportunities for the timely provision of health services to
contact, the partners of people living with HIV (PLWH)
partners of PLWH. This situation
1-3 can preclude the successful
concentrate major health needs .
implementation of treatment as prevention for serodiscordant
couples.
Within the concept of Treatment as Prevention (TasP),
antiretroviral (ARV) therapy to PLWH in serodiscordant couples
is being progressively implemented 4-5, as recently occurred in
Peru6. However, partners identification and notification still
collide with ethical and legal aspects.
Index
cases
(n=48)
N (%)
HIV-positive
partners
(n=48)
N (%)
19(40)
2(4)
0.36
0(0)
39(82)
0.82
7(15)
0(0)
0.15
7(15)
2(4)
0.11
3(6)
1(2)
0.04
12(24)
4(8)
0.16
Prevalence
difference
P [IC]
Others
<0.001
(0.21,0.51)
<0.001
(0.71,0.93)
0.005
(0.05,0.25)
0.06 (0.01,0.23)
0.3 (-0.04,0.12)
Unknown
0.03 (0.02,0.3)
WHO Clinical
Stage IV at
enrollment
Late tester
14 (30)
3 (7)
0.23
22 (46)
15 (32)
0.14
Indication of
30(63)
23 (49)
0.14
HAART
Linkage to care
30 (63)
23 (49)
0.14
Viral suppression
26/34 (77)
Limitations
31/42 (74)
0.03
0.003
(0.09,0.38)
0.16 (0.05,0.33)
0.18 (0.06,0.33)
0.18 (0.06,033)
0.75 (-
0.19,0.14)
We did not have information of disclosure rates to partners
or
Hospital
23/139 (17) 8/184 (4)
0.12
<0.001
information
of
partners
that
might
receive
care
in other
admission
(0.05,0.19)
health
centers.
index
(personyear)
In spite of <%5 missing data, probably not every couple
Mortality
3(6)
0(0)
0.06
0.08 (0.01,0.13)
could be identified
and matched.
We excluded subjects with multiple partners and did not
consider sexual orientation, as such information was limited
in the original data sources.
Conclusions
Maartens G, Celum C, Lewin S. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 2014;384:258-71
Fideli U, Allen S, Musonda R, Trask B, Hahn H, et al. Virologic and immunologic determinants of heterosexual transmission of HIV-type 1(HIV-1) in Africa. AIDS Res Hum Retrovir. 2001;17:90110.
Vermund SH. Global HIV epidemiology: a guide for strategies in prevention and care. Curr HIV/AIDS Rep. 2014;11:9398.
Vermund S, Van Lith L, Holtgrave D. Strategic roles for health communication in combination HIV prevention and care programs. J Acquir Immune Defic Syndr. 2014;66(3):237-40
WHO. Guidance On Couples HIV Testing And Counselling Including Antiretroviral Therapy For Treatment And Prevention In Serodiscordant Couples: Recommendations for a public health approach.
Geneva, Switzerland: World Health Organization;2012
6. Ministerio de Salud del Per. Norma Tcnica de Salud de Atencin Integral Del Adulto con Infeccin por El Virus de La Inmunodeficiencia Humana (VIH). Lima, Per:MINSA;2014.
7. Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA (ONUSIDA) Informe Nacional sobre los progresos realizados en el pas, Per. Periodo 2012 diciembre 2013 [Internet] Ginebra, Suiza:
ONUSIDA; 2014. [citado el 10 ene de 2015]. Disponible en: http://www.unaids.org/en/dataanalysis/knowyourresponse/ countryprogressreports/2014countries